How deadly is Colon cancer?

['Ehendu ko kuatiarogue']

Mba'eichaite pevépa ikatu omano cáncer de colon?

Cáncer de colon, ojekuaáva avei cáncer colorrectal-ramo, ha'e peteĩ mba'asy ivaíva ha ikatúva oporojuka.

Ha'e mbohapyha tendagua cáncer ojehechavéva Estados Unidos-pe ha mokõiha tendagua cáncer ñemano.

Upe tasa de supervivencia 5 ary pukukue cáncer de colon-pe g̃uarã ha'e 65% rupi, katu iñambue ojehecha rire mba'e estadio-pepa ojejuhu.

Ojehecha pya'éramo, tasa de supervivencia 5 ary ikatu ojupi 90% peve, katu cáncer isarambíramo ambue tendápe, tasa de supervivencia oguejy 111% rupi.

Iporã oje'e umi tasa de supervivencia ha'eha estimación añónte ha umi resultado individual ikatu iñambue.

Jehecha jey jey ha ñepohano pya'e ikatu tuicha omboguejy upe riesgo colon rehegua cáncer-gui.

['Jehechapy']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Andersen LD, Remington P, Trentham-Dietz A, Reeves M: Assessing a decade of progress in cancer control. Oncologist. 2002, 7 (3): 200-4.

Wang YG, Chen KX, Wu GL, Song FJ: An analysis: colon cancer mortality in Tianjin, China, from 1981 to 2000. World J Gastroenterol. 2005, 11 (6): 895-8.

Tsuji K, Harashima E, Nakagawa Y, Urata G, Shirataka M: Time-lag effect of dietary fiber and fat intake ratio on Japanese colon cancer mortality. Biomed Environ Sci. 1996, 9 (2-3): 223-8.

Kanter MH, Schottinger JE, Joshua A, Slezak JM: Beyond Screening: An Interim Report and Analysis of a Multimodal Initiative to Decrease Colon Cancer Mortality. Jt Comm J Qual Patient Saf. 2022, 48 (8): 388-394.

Tseng CH: Diabetes but not insulin is associated with higher colon cancer mortality. World J Gastroenterol. 2012, 18 (31): 4182-90.

Jacobs EJ, Connell CJ, Patel AV, Chao A, Rodriguez C, Seymour J, McCullough ML, Calle EE, Thun MJ: Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (United States). Cancer Causes Control. 2001, 12 (10): 927-34.

['Ñemboyke: pohã']

["Ko página web niko ñehekombo'e ha marandu rehegua añónte, ndaha'éi ñeporandu térã ñepytyvõ pohãnohárape."]

["Ko marandu oñeme'ẽva ndojeporúi va'erã ojeikuaa térã oñepohano hag̃ua peteĩ problema de salud térã mba'asy, ha umi tapicha ohekáva consejo médico ha'eñoháme oñe'ẽva'erã peteĩ pohanohára ikatupyrýva ndive."]

["Ejesareko ta'ãngamýi ñandutigua omoheñóiva mbohovái porandukuérape, noĩporãi ojeipapávo papapy rehegua, techapyrã, tapichakuéra hasýva peteĩ mba'asýpe."]

["Akóinte eheka ne pohãnohára térã ambue pohanohára ikatupyrýva ñe'ẽ peteĩ mba'asýpe. Ani araka'eve remboyke térã reha'arõ'ỹ rehekávo ñe'ẽ pohanohára ikatupyrýva ñe'ẽ remoñe'ẽre ko ñanduti rendápe. Reimo'ãramo ikatuha reikotevẽ peteĩ mba'e hasýva, ehenoikuaa 911 térã tereho pya'e tasyópe. Ko ñanduti renda térã ijeporu ndojapói mba'eveichagua pohanohára ha hasýva jokupyty. BioMedLib, imba'apohára térã oimeraẽ tapicha oipytyvõva ko ñanduti rendápe, nomboajéi mba'eve, he'íva térã he'iséva, marandu oĩva ko'ápe térã ijeporu."]

['Copyright: Copyright']

["Pe Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (DMCA) ome'ẽ recurso umi copyright járape ogueroviáva umi mba'e ojehechaukáva Internet-pe opokovaiha iderecho rehe EE.UU. léi jehaiporãmby rehegua rupive. "]

["Rogueroviáramo añetehápe oimeraẽ mba'e térã tembiporu ojepurukuaáva ore ñanduti renda térã tembipurupyahu rupive opyrũha ne derécho rehe, nde (térã ne rembijokuái) ikatu oremondo peteĩ ñemomarandu ojerurévo ojeipe'a hag̃ua upe mba'e térã tembiporu, térã ojejokopa hag̃ua ijeike. "]

['Umi ñemomarandu oñemog̃uahẽva\'erã kuatia rupive, correo electrónico rupive (ojehecháta "Contacto" pe).']

["DMCA ojerure ne ñemomarandu rehe ejaposégui mba'evai ejaposéva rehe toike ko'ã mba'e: (1) tembiapo ojejaposéva rehegua ha'éva mba'evai; (2) jehaipy ha mba'ekuaarã ome'ẽva oréve jehaipyre ha'éva mba'evai ha ome'ẽva oréve pa'ũ rojuhu hag̃ua; (3) ne ñanduti veve, ne rendaite, ne pumbyry papapy ha ne ñanduti veve; (4) ñe'ẽme'ẽ erekóva rejeroviaha pe mba'evai ejaposéva rehe ndojeruréiha mba'evai apohára, imaranduhára térã léi."]

["5. peteî declaración nde rejapóva, remoîva nde réra ha remoîva'erâha nde jurúpe, umi mba'e oîva ñemomarandúpe oîmbaha añetehápe ha rerekoha pokatu remoañete haguâ umi derecho oje'éva nde rehe ojepoko vaiha;"]

["ha (6) peteĩ firma física térã electrónica copyright jára rehegua térã peteĩ tapicha omoneĩva oporoñemomba'e hag̃ua copyright jára rérape. "]

["Ndoikéi ramo opaite ko'ã mba'e ikatu ombohape nde denuncia ñemboguata."]

['Ñemboheraguapy']

["Remba'eporanduséramo térã ereko hag̃ua ne remiandu ehai oréve."]

How deadly is colon cancer?

Colon cancer, also known as colorectal cancer, is a serious and potentially deadly disease.

It is the third most common cancer in the United States and the second leading cause of cancer deaths.

The overall 5-year survival rate for colon cancer is approximately 65%, but this varies depending on the stage at which the cancer is diagnosed.

If caught early, the 5-year survival rate can be as high as 90%, but if the cancer has spread to other parts of the body, the survival rate drops to around 111%. Early detection and treatment are crucial for improving the chances of survival.

It is important to note that survival rates are only estimates and individual outcomes may vary.

Regular screening and prompt treatment can significantly reduce the risk of colon cancer becoming deadly.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.